Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report

Myung- Ah Lee

首页> 外文期刊>Gastrointestinal Cancer Research >Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report

【24h】

Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report

机译：吉西他滨/厄洛替尼（GE）和吉西他滨/卡培他滨（GX）在无法切除的胰腺癌中的疗效比较：回顾性，单中心经验，最终报告

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Gastrointestinal Cancer Research》 |2012年第2期|共1页
作者
Myung- Ah Lee;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类消化系及腹部疾病;
关键词
入库时间 2022-08-18 10:31:59

相似文献

外文文献
中文文献
专利

1. Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer [J] . JeonE.K., WonH.-S., KoY.-H., Journal of Cancer Research and Clinical Oncology . 2012,第10期

机译：吉西他滨联合卡培他滨（GC）与吉西他滨联合厄洛替尼（GE）在不可切除的胰腺癌中的疗效和毒性比较
2. Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer [J] . Eun Kyoung Jeon, Hye-Sung Won, Yoon-Ho Ko, Journal of Cancer Research and Clinical Oncology . 2012,第10期

机译：吉西他滨联合卡培他滨（GC）与吉西他滨联合厄洛替尼（GE）在不可切除的胰腺癌中的疗效和毒性比较
3. Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: Final results of a randomised phase 3 trial of the 'arbeitsgemeinschaft internistische onkologie' (AIO-PK0104) [J] . HeinemannV., Vehling-KaiserU., WaldschmidtD., Gut: Journal of the British Society of Gastroenterology . 2013,第5期

机译：吉西他滨联合厄洛替尼联合卡培他滨与卡培他滨联合厄洛替尼联合吉西他滨治疗晚期胰腺癌：“ arbeitsgemeinschaft internistische onkologie”随机3期试验的最终结果（AIO-PK0104）
4. Ultrasound microbubble targeted gemcitabine delivery for pancreatic cancer treatment [C] . Lauren J. Jablonowski, John R. Eisenbrey, David Brown, IEEE International Ultrasonics Symposium . 2017

机译：超声微泡靶向吉西他滨递送治疗胰腺癌
5. Formulation, Optimization and Efficacy of Gemcitabine Loaded Thermosensitive Liposomal Nanoparticles in the Treatment of Pancreatic Cancer [D] . Affram, Kevin Osei. 2018

机译：吉西他滨负载热敏脂质体纳米颗粒的制备，优化及疗效
6. Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective Single Center Experience Final Report [O] . Myung- Ah Lee 2012

机译：吉西他滨/厄洛替尼（GE）和吉西他滨/卡培他滨（GX）在无法切除的胰腺癌中的疗效比较：回顾性单中心经验最终报告
7. Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104) [O] . Volker Heinemann, Ursula Vehling-Kaiser, Dirk Waldschmidt, 2012

机译：Gemcitabine Plus erlotinib随后Capecitabine与Capecitabine Plus erlotinib接下来是晚期胰腺癌中的吉西他滨：ArbeitsGemeinschaft Internistische Onkologie的随机阶段3试验的最终结果（Aio-PK0104）

Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report

著录项

相似文献

相关主题

期刊订阅